Cargando…
Can the general public use vignettes to discriminate between Alzheimer’s disease health states?
BACKGROUND: Valid estimates of health-related quality-of-life (HRQoL) are often difficult to obtain from persons with Alzheimer’s disease (AD) and family caregiver proxies. To help assess whether the general public can serve as an alternate source of proxy HRQoL estimates in AD, we examined whether...
Autores principales: | Oremus, Mark, Xie, Feng, Pullenayegum, Eleanor, Gaebel, Kathryn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4738787/ https://www.ncbi.nlm.nih.gov/pubmed/26842500 http://dx.doi.org/10.1186/s12877-016-0207-4 |
Ejemplares similares
-
Development of Clinical Vignettes to Describe Alzheimer's Disease Health States: A Qualitative Study
por: Oremus, Mark, et al.
Publicado: (2016) -
How Does the Canadian General Public Rate Moderate Alzheimer's Disease?
por: Tarride, Jean-Eric, et al.
Publicado: (2011) -
Identifying the components of clinical vignettes describing Alzheimer’s disease or other dementias: a scoping review
por: Randhawa, Harkanwal, et al.
Publicado: (2015) -
Support for a tax increase to provide unrestricted access to an Alzheimer's disease medication: a survey of the general public in Canada
por: Oremus, Mark, et al.
Publicado: (2009) -
A Time Trade-off-derived Value Set of the EQ-5D-5L for Canada
por: Xie, Feng, et al.
Publicado: (2016)